Postoperative radiotherapy after tracheal reconstruction with cryopreserved aortic allograft for adenoid cystic carcinoma.

Authors

Arnaud Beddok, Nicolas Venissac, Marine Boulesteix, Gaëtan Deslée, Laurence Gérinière, Ilaria Onorati, Florence Le Tinier, Julie Malet, Adrien Paix, Dana Radu, François Tronc, Françoise Mornex, Emmanuel Martinod

Published in

Practical radiation oncology. Sep 11, 2026. Epub Sep 11, 2026.

Abstract

Tracheal reconstruction using cryopreserved aortic allografts has enabled radical resection of extensive central airway tumors, including adenoid cystic carcinoma (ACC). However, the safety and feasibility of postoperative radiotherapy (RT) in this setting remain undocumented, particularly given the unknown radiation tolerance of the non-vascularized graft.
Four patients from a prospective institutional cohort underwent tracheal or tracheobronchial resection followed by reconstruction with a cryopreserved aortic allograft and received adjuvant RT. Target volumes were defined based on surgical and pathological findings. The graft was not considered a target structure but was partially included in the clinical target volume (CTV) when immediately adjacent to high-risk areas. RT was delivered using a split-course, normofractionated volumetric modulated arc therapy (VMAT) regimen to a total dose of 54 Gy (30 Gy in 15 fractions followed by 24 Gy in 12 fractions).
RT was completed as planned in all patients. In three cases, limited portions of the graft were included in the CTV, while the remainder was spared. Two patients experienced clinically significant postoperative events before RT initiation, which resolved prior to treatment. During RT, one patient developed a transient inflammatory syndrome with cough and fever, which resolved with conservative management. No other acute grade ≥2 toxicity occurred. No graft-related inflammatory reaction, intolerance, or imaging abnormality was observed. After a median follow-up of 12 months, all patients were alive. No local recurrences were observed, and one patient developed distant pulmonary metastases.
Postoperative RT after tracheal reconstruction with a cryopreserved aortic allograft appears feasible and clinically manageable. A strategy combining selective target coverage and graft sparing may allow safe integration of RT in this setting and inform treatment planning in similar high-risk cases.

PMID:
42727774
Bibliographic data and abstract were imported from PubMed on 12 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.